Results 171 to 180 of about 416,102 (337)
ESC Heart Failure, EarlyView.We investigated cardiometabolic outcomes in patients treated with dapagliflozin 10 mg once daily or placebo after acute myocardial infarction according to LVEF at randomisation in the registry‐based, randomised DAPA‐MI trial. Regardless of baseline LVEF, dapagliflozin resulted in significant cardiometabolic benefits versus placebo, suggesting that ...
David Erlinge +19 more
wiley +1 more source
Patient Preference and AdherenceJian Yu,1,* Hong Wang,1,* Min Zhu,1,* Meijing Zhou,1 Jingjing Xu1– 3 1Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing, LA, 210029, People’s Republic of China ...
Yu J, Wang H, Zhu M, Zhou M, Xu J
doaj
Polymorphisms of the _ENPP1_ gene are not associated with type 2 diabetes or obesity in the Chinese Han population [PDF]
, 2008 *Objective:* Type 2 Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia and with a major feature of insulin resistance. Genetic association studies have suggested that _ENPP1_ might play a potential role in susceptibility to ...
Daizhan Zhou +11 more
core +1 more source
ESC Heart Failure, EarlyView.A study of 660 heart failure patients (mean age 76.1) found that polypharmacy was common, with only 5% discharged without it, and 60% had died by the end of a median 2.9‐year follow‐up. In patients with heart failure with reduced ejection fraction (HFrEF), hyperpolypharmacy was associated with significantly higher mortality, while in those with ...
Janine Beezer +4 more
wiley +1 more source
Infection and Drug ResistanceKazuhiro Furumachi,1 Tatsuki Kagatsume,2 Akari Higuchi,2 Mariko Kozaru,2 Etsuko Kumagai,1 Keiko Hosohata2 1Department of Nephrology, Kenwakai Hospital, Nagano, Japan; 2Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka ...
Furumachi K +5 more
doaj
Journal of Family Medicine and Primary CareBackground: Type 2 Diabetes (T2D) is a global challenge with rising prevalence, inadequate compliance, and poor outcomes. Aims: Assess the effect of a 2-only-daily-meals with exercise lifestyle (2-OMEX) on (a) HbA1c, (b) anti-diabetic medication count ...
Shyam V Ashtekar +3 more
doaj +1 more source
European Journal of Heart Failure, EarlyView.The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg +17 more
wiley +1 more source
آموزش بهداشت و ارتقاء سلامت ایران, 2017 Background and objective: Diabetes is a serious and a chronic disease. With proper training diabetes can be prevented up to 80%. Therefore, patients with diabetes should be trained in terms of self-care due to the reason that the most important factor of
Morteza Porgholmi +3 more
doaj
European Journal of Heart Failure, EarlyView.ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura +23 more
wiley +1 more source
European Journal of Heart Failure, EarlyView.The value of uACR. CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; uACR, urine albumin‐to‐creatinine ratio. Abstract The high disease burden and bidirectional relationship of chronic kidney disease (CKD), heart failure (HF) and other cardiovascular disease (CVD) necessitate the need for early ...
Biykem Bozkurt +2 more
wiley +1 more source